Successful chimeric Ag receptor modified T cell therapy for isolated testicular relapse after hematopoietic cell transplantation in an acute lymphoblastic leukemia patient

Bone Marrow Transplant. 2017 Jul;52(7):1065-1067. doi: 10.1038/bmt.2017.64. Epub 2017 Apr 24.

Authors

J Yu¹, Y Hu¹, C Pu², Z Liang¹, Q Cui³, H Zhang¹, Y Luo¹, J Shi¹, A Jin¹, L Xiao², Z Wu², H Huang¹

Affiliations

¹ Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
² Innovative Cellular Therapeutics Co., Ltd, Shanghai, China.
³ Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

PMID: 28436979
DOI: 10.1038/bmt.2017.64

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Allografts
Hematopoietic Stem Cell Transplantation*
Humans
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / therapy
Receptors, Antigen, T-Cell*
Recombinant Fusion Proteins
Recurrence
T-Lymphocytes / transplantation*
Testicular Neoplasms* / pathology
Testicular Neoplasms* / therapy

Substances

Receptors, Antigen, T-Cell
Recombinant Fusion Proteins